Next Article in Journal
Role of Diuretics and Ultrafiltration in Congestive Heart Failure
Next Article in Special Issue
Characterization of Antimicrobial Peptides toward the Development of Novel Antibiotics
Previous Article in Journal
Current Challenges and Future Directions in Recombinant AAV-Mediated Gene Therapy of Duchenne Muscular Dystrophy

Diamidines versus Monoamidines as Anti-Pneumocystis Agents: An in Vivo Study

Laboratory of Organic Chemistry, University of Mons-UMONS, B-7000 Mons, Belgium
Biology & Diversity of Emerging Eukaryotic Pathogens (BDEEP), Center for Infection and Immunity of Lille (CIIL), INSERM U1019, CNRS UMR 8204, EA-4547, Univ Lille Nord de France, UDSL, Institut Pasteur de Lille, F-59000 Lille, France
EA2694, Department of Biostatistics, Université de Lille Nord de France, F-59000 Lille, France
Department of General, Organic, and Biomedical Chemistry, NMR and Molecular Imaging Laboratory, University of Mons-UMONS, B-7000 Mons, Belgium
CHU Lille, Biology & Pathology Center, Parasitology-Mycology, F-59000 Lille, France
Author to whom correspondence should be addressed.
Pharmaceuticals 2013, 6(7), 837-850;
Received: 22 April 2013 / Revised: 14 May 2013 / Accepted: 17 June 2013 / Published: 1 July 2013
(This article belongs to the Special Issue Antimicrobial Agents)
Some compounds articulated around a piperazine or an ethylenediamine linker have been evaluated in vitro to determine their activity in the presence of a 3T6 fibroblast cell line and an axenic culture of Pneumocystis carinii, respectively. The most efficient antifungal derivatives, namely N,N′-bis(benzamidine-4-yl)ethane-1,2-diamine (compound 6, a diamidine) and N-(benzamidine-4-yl)-N′-phenylethane-1,2-diamine (compound 7, a monoamidine), exhibited no cytotoxicity and were evaluated in vivo in a rat model. Only the diamidine 6 emerged as a promising hit for further studies. View Full-Text
Keywords: Pneumocystis; pentamidine; diamidine Pneumocystis; pentamidine; diamidine
Show Figures

Graphical abstract

MDPI and ACS Style

Stanicki, D.; Pottier, M.; Gantois, N.; Pinçon, C.; Forge, D.; Mahieu, I.; Boutry, S.; Vanden Eynde, J.J.; Martinez, A.; Dei-Cas, E.; Aliouat, E.-M. Diamidines versus Monoamidines as Anti-Pneumocystis Agents: An in Vivo Study. Pharmaceuticals 2013, 6, 837-850.

AMA Style

Stanicki D, Pottier M, Gantois N, Pinçon C, Forge D, Mahieu I, Boutry S, Vanden Eynde JJ, Martinez A, Dei-Cas E, Aliouat E-M. Diamidines versus Monoamidines as Anti-Pneumocystis Agents: An in Vivo Study. Pharmaceuticals. 2013; 6(7):837-850.

Chicago/Turabian Style

Stanicki, Dimitri, Muriel Pottier, Nausicaa Gantois, Claire Pinçon, Delphine Forge, Isabelle Mahieu, Sébastien Boutry, Jean Jacques Vanden Eynde, Anna Martinez, Eduardo Dei-Cas, and El-Moukhtar Aliouat. 2013. "Diamidines versus Monoamidines as Anti-Pneumocystis Agents: An in Vivo Study" Pharmaceuticals 6, no. 7: 837-850.

Find Other Styles

Article Access Map by Country/Region

Only visits after 24 November 2015 are recorded.
Back to TopTop